Lantheus Holdings (LNTH)

Jun 2, 2025, 8:00 AM EDT - 1 day ago

PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

GEHC

May 14, 2025, 3:26 PM EDT - 19 days ago

Lantheus Holdings: Poor Results Caused By Temporary Problems - A Buy

May 8, 2025, 6:50 PM EDT - 25 days ago

Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH

May 7, 2025, 11:23 AM EDT - 26 days ago

Lantheus Holdings, Inc. (LNTH) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:01 PM EDT - 27 days ago

Lantheus Announces Sale of SPECT Business to SHINE Technologies

Apr 30, 2025, 8:30 AM EDT - 4 weeks ago

Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

Apr 23, 2025, 8:30 AM EDT - 5 weeks ago

Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time

Apr 1, 2025, 9:00 AM EDT - 2 months ago

Lantheus Completes Acquisition of Evergreen Theragnostics

Mar 7, 2025, 11:12 AM EST - 3 months ago

Lantheus Holdings: Pylarify Makes Bull Case Despite Looming Patent Expiry

Feb 26, 2025, 10:49 AM EST - 3 months ago

Lantheus Holdings, Inc. (LNTH) Q4 2024 Earnings Call Transcript

Jan 30, 2025, 8:30 AM EST - 4 months ago

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D.

Jan 28, 2025, 6:30 AM EST - 4 months ago

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

Jan 13, 2025, 12:05 AM EST - 5 months ago

Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer's Disease Radiodiagnostic Market

Jan 1, 2025, 7:43 PM EST - 5 months ago

Lantheus Holdings: Powerhouse Potential In 2025

Dec 12, 2024, 2:01 PM EST - 6 months ago

Lantheus Holdings: A Growing Business With Dominant Market Share

Nov 20, 2024, 1:00 AM EST - 6 months ago

Lantheus Announces Share Repurchase Program

Nov 13, 2024, 8:30 AM EST - 7 months ago

Lantheus to Present at the Jefferies London Healthcare Conference

Nov 11, 2024, 7:39 AM EST - 7 months ago

Lantheus Continues to Commend CMS' CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY's Blockbuster Status for 2025

Nov 8, 2024, 10:06 AM EST - 7 months ago

Lantheus Holdings: Q3 Results Were Good But Market Overreacted

Nov 6, 2024, 11:27 AM EST - 7 months ago

Lantheus Holdings, Inc. (LNTH) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 7:30 AM EST - 7 months ago

Lantheus Applauds CMS' CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care

Oct 23, 2024, 8:30 AM EDT - 7 months ago

Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time

Sep 15, 2024, 8:45 AM EDT - 9 months ago

Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024

Sep 5, 2024, 8:30 AM EDT - 9 months ago

Lantheus Appoints Julie Eastland as New Board Member

Aug 28, 2024, 8:30 AM EDT - 9 months ago

Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 12, 2024, 3:32 PM EDT - 10 months ago

Lantheus: A Radiopharmaceutical Powerhouse In The Making (Q2 2024 Update)

Aug 12, 2024, 7:15 AM EDT - 10 months ago

13 stocks to consider if you're able to brave recession fears

CWAN ESNT FUL ISRG KO MA MKTX

Jul 31, 2024, 12:18 PM EDT - 10 months ago

Lantheus Holdings, Inc. (LNTH) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 7:00 AM EDT - 10 months ago

Lantheus Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 2:00 AM EDT - 11 months ago

10 Stocks That Star Small-Cap Funds Love

ATKR AZEK FIX FN HQY MOD MTDR

Jul 17, 2024, 8:30 AM EDT - 11 months ago

Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time

Jul 15, 2024, 8:30 AM EDT - 11 months ago

Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer's Disease

Jul 12, 2024, 11:40 AM EDT - 11 months ago

Lantheus' Strategic Advantage Amplified By New CMS Payment Refinements (Rating Upgrade)

Jul 10, 2024, 12:32 PM EDT - 11 months ago

Lantheus Welcomes CMS' Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access

Jul 8, 2024, 8:30 AM EDT - 11 months ago

Lantheus Appoints Jamie Spaeth as Chief People Officer

Jun 27, 2024, 7:05 AM EDT - 1 year ago

Lantheus Acquires Global Rights to Life Molecular Imaging's Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers

Jun 20, 2024, 8:41 PM EDT - 1 year ago

Radiopharm Receives Strategic Investment for up to A$18 million

Jun 3, 2024, 8:30 AM EDT - 1 year ago

Lantheus' AI-Enabled aPROMISE Now Available on Siemens Healthineers' syngo.via platform

May 28, 2024, 8:00 AM EDT - 1 year ago

Lantheus to Present at the William Blair 44th Annual Growth Stock Conference

May 23, 2024, 12:36 PM EDT - 1 year ago

Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus